Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AlbigesL
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AlbigesL
-
Laurence Albiges proslijedio/la je Tweet
The latest
#January issue of@EurUrolOncol is now live https://euoncology.europeanurology.com/current Featuring:#prostatecancer: MRI-directed biopsy strategies#bladdercancer: local surgery in metastatic disease#kidneycancer: how to manage renal#angiomyolipoma … and much more! Happy reading!pic.twitter.com/c4SwhOZ6xw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations from overseas , well deserved
@montypal@cityofhopehttps://twitter.com/neerajaiims/status/1222412843040952321 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to all ! Major step forward for RCC research and patient care
@advocatekidneys@IKCCorg@KidneyCancer@kcCURE@AssoARTuRhttps://twitter.com/advocatekidneys/status/1207017852508790784 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Laurence Albiges proslijedio/la je Tweet
Prof. Jean-Charles Soria appointed General Director of
@GustaveRoussy by the french Minister of Solidarity and Health@AgnesBuzyn, for a term of 5 years. Read more
https://www.gustaveroussy.fr/en/professor-jean-charles-soria-appointed-general-director-gustave-roussy … @jsoriamdpic.twitter.com/hezViOLMte
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Major debate
#SOGUG19 on the data available in good risk IMDC pts - combination VEGF-IO regimens over single agent TKI in VEGF driven disease@PGrivasMDPhD@DrChoueiri ultimately aiming the cure so IO needed@Uromigoshttps://twitter.com/PGrivasMDPhD/status/1200345180676726784 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Laurence Albiges proslijedio/la je Tweet
The latest
#November issue of@EurUrolOncol is now available for download! https://euo-2-6.elsevierdigitaledition.com/ Featuring:#prostatecancer: RCTs of#MRI-targeted vs systematic biopsy#bladdercancer: role of variant histology in MIBC#kidneycancer: 1st line treatment of mRCC Happy reading!pic.twitter.com/umgvirWTkY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Important to characterize unconventional/mixed response with IO in mRCC. NIVOREN
@GETUG_Unicancer is the right cohort to expand our understanding of this phenomenon and ultimately understand the biology behind@SamraTurajlic#tumorheterogeneityhttps://twitter.com/CCaramellaigr/status/1197158877516705792 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud of
@GustaveRoussy 10 (yes , 10!)#HighlyCitedResearchers listed@webofscience#HighlyCited2019 ! Congrats to all@FAndreMD@jsoriamd for fantastic science#cancer@UnivParisSaclayhttps://twitter.com/GustaveRoussy/status/1196830833803505664 …
0:20Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Many thanks to the
#EMUC19 staff for their organisation@myESMO@Uroweb Looking forward Athens#EMUC20https://twitter.com/JarkaBloemberg/status/1196018515783933952 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EMUC19 is honored to host our international guest speakers@neerajaiims@UroDocAsh@MDAndersonNews@ArjunBalarMD@KlotzLaurence@myESMOpic.twitter.com/ug49fHsQV7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Laurence Albiges proslijedio/la je Tweet
#EMUC@myESMO Current and evolving management of BCG refractory non muscle invasive bladder cancer. Excellent overview by@UroDocAsh@MDAndersonNews Valrubicin is the only approved agent and clinical trials are preferred. Approval of pembro will change the Rx landscape.pic.twitter.com/Z1XtbPutid
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Laurence Albiges proslijedio/la je Tweet
Having
@BradLeibovichMD give a lecture on RCC prognostic factors during#ARTuR2019 is a jewel. It is like having@motzermd giving a talk on mRCC clinical trials. Oh...wait...did we have both ??#bestsympoever#patientscare#giantsincancercare@MejeanArnaud@AlbigesLpic.twitter.com/4cjC8qsyAa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Amazing what Benard ESCUDIER &
@MejeanArnaud have achieved together with@AssoARTuR over these 14 years#ARTUR2019 in the field of mRCC! Role models to all of us@UrologieParis Thanks@IdirOuzaid for the#youhaventchanged picture@GustaveRoussy@AFUrologie@GETUG_Unicancerhttps://twitter.com/uroccr/status/1182608544513871873 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kicking off the 8th edition of
#ARTUR2019 with biology insight on mRCC evolution from our international guest star@SamraTurajlic seminal work from@CharlesSwanton labpic.twitter.com/jKIrInWfjm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Laurence Albiges proslijedio/la je Tweet
Le Pr Jean-Yves Blay élu président de la fédération Unicancer https://www.apmnews.com:443/story.php?objet=341713apmnews.com/story.php?obje …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Couldn’t agree more on
@FabioSchutz78 fantastic coverage of#ESMO19 and GU meetings! Thank you Fabio#WCRM@DrChoueiri@g_develasco@DrAndreFayhttps://twitter.com/UrologieParis/status/1178780549156089856 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proposed (personal opinion) new guidelines for 1st line mRCC by Dr Bernard ESCUDIER
#ESMO19@DrChoueiri@Uromigospic.twitter.com/fcHMUc1jqB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2 more mRCC trials in “immunotherapy of cancer” session
#ESMO19 to be discussed by Bernard ESCUDIER don’t miss lenva-pembro compelling RR after prior IO exposure !pic.twitter.com/zpA0m8WmAc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ESMO2019 Starting now GU Poster discussants@OncoBellmunt@g_develasco ready to present new works across RCC/UC/GCT!pic.twitter.com/lmjNWJ1UBm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Completed first day of lively debate for the 2020 update
@EauGuidelines@Uroweb@IKCCorg@Uromigos@MichaelStaehler fantastic commitment@amerseburger@DrDabestani special thanks to our host@foxal72 https://twitter.com/MichaelStaehler/status/1169923161376350208 …pic.twitter.com/Tv5bzkhwHx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

10 experts de
Découvrez-les sur :